[0K6R] YoY Annual Result on 31-Dec-2021 [#FY]

Stock
[0K6R] Neurocrine Biosciences, Inc.
Announcement Date
11-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#FY]
Profit Trend
YoY- -78.00%
Quarter Report
0K6R's Result
0K6R's Financial Summary
View:
Show?
Annual Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 2,355,300 1,887,100 1,488,700 1,133,500 1,045,900 788,100 451,200 31.67%
PBT 486,000 332,100 213,900 101,400 106,700 46,500 21,841 67.63%
Tax 144,700 82,400 59,400 11,800 -300,600 9,500 730 141.27%
NP 341,300 249,700 154,500 89,600 407,300 37,000 21,111 58.94%
Tax Rate -29.77% -24.81% -27.77% -11.64% 281.72% -20.43% -3.34% -
Total Cost 2,014,000 1,637,400 1,334,200 1,043,900 638,600 751,100 430,089 29.31%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 14.49 13.23 10.38 7.90 38.94 4.69 4.68 20.70%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS 3.40 2.56 1.61 0.95 4.37 0.40 0.22 57.75%
EPS Diluted 3.29 2.47 1.56 0.92 4.16 0.39 0.22 56.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.